1. AbramovaEV, DygaiAM, GoldbergVE (1991). Effect of Scutellaria baicalensis Georgi extract on the hemato-poiesis regeneration in C57BL/6 mice with Lewis lung carcinoma under cyclophosphan treatment [Vliyanie ekstrakta shlemnika baykal’skogo na regeneratsiyu krovetvoreniya u myshey linii S57V1/6 s kartsinomoy L’yuisa, poluchavshikh tsiklofosfan]. Eksperimental’naya onkologiya, 13(6), 68-70.

2. AntoneevaII, GeningTP (2007). Neutrophil granu-locytes in the dynamics of ovarian cancer [Neytrofil’nye granulotsity v dinamike progressii raka yaichnikov]. Klinicheskaya laboratornaya diagnostika, (8), 43-46.

3. GlantzS (1998). Biomedical statistics [Mediko-bio-logicheskaya statistika], 459

4. GoldbergED, DygaiAM, ShakhovVP (1992). Hemato-logical methods of tissue culture [Metody kul’tury tkani v gematologii], 264.

5. DygaiAM, ZhdanovVV (2012). Theory of hematopoi-esis regulation [Teoriya regulyatsii krovetvoreniya], 140.

6. ZuevaEP, KozlovAM, GerasimovaGK, AmosovaEN, RazinaTG, GoldbergED (2005). Guidelines for preclinical study of agents with the ability to inhibit the metastasis process and to improve the efficiency of cytostatic ther-apy of malignant tumors [Metodicheskie ukazaniya po doklinicheskomu izucheniyu sredstv, obladayushchikh sposobnost’yu ingibirovat’ protsess metastazirovaniya i povyshat’ effektivnost’ tsitostaticheskoy terapii zlo-kachestvennykh opukholey]. Rukovodstvo po eksperimen-tal’nomu (doklinicheskomu) izucheniyu novykh farmako-logicheskikh veshchestv, 674-682.

7. KormanDB (2006). Basics of anticancer chemother-apy [Osnovy protivoopukholevoy khimioterapii], 512.

8. KokorevOV, CherdyntsevaNV, ZyuzikovaOV (2006). Method of increasing antitumor and antimetastatic activ-ity of cyclophosphamide in experiment: Patent 2270682 of the Russian Federation [Sposob povysheniya protivoopuk-holevoy i antimetastaticheskoy aktivnosti tsiklofosfana v eksperimente: Pat. No 2270682 Ros. Federatsiya].

9. ChuE, DeVitaJr.V (2009). Chemotherapy of tumors [Khimioterapiya zlokachestvennykh novoobrazovaniy], 455.

10. Experimental evaluation of anticancer drugs in the USSR and the United States (1980). [Eksperimen-tal’naya otsenka protivoopukholevykh preparatov v SSSR i SShA],296

11. AbaidLN, MichaJP, RettenmaierMA BrownJV, MendivilAA, LopezKL, GoldsteinBH (2013). A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma. Cancer Chemother. Pharmacol., (May 10).